Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. Academics have long referred to their field as a leaky pipeline — ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The last time Jay Bhattacharya testified before Congress, in early ...

A silhouette of a person looking through a microscope with a red computer screen in the background. Researchers looking for NIH funding in 2026 will likely find increased competition and ...

Though the federal government has passed a funding bill increasing the budget available for the National Institutes of Health, the biomedical research powerhouse is still lagging behind previous years ...

A federal appeals court upheld an injunction Monday that prevents the National Institutes of Health (NIH) from making cuts that would’ve translated to hundreds of millions of dollars in lost grant ...

National Institutes of Health (NIH) Director Jay Bhattacharya will testify before the House Appropriations Committee on Tuesday morning on oversight of the research agency. Still, a recent poll shows ...

A striking change in how the world’s largest biomedical funding agency solicits research proposals has sparked debate about how it should fund science. US science after a year of Trump: what has been ...

As a life science project progresses, it can travel through different domains of science, or at least the purviews of different government regulators. A project to produce novel molecules might start ...

National Institutes of Health Director Jay Bhattacharya testified Tuesday in an oversight hearing before the House Appropriations Committee. Watch in our video player above. The NIH under the Trump ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling an openness to new approaches that haven’t been validated and the National ...